About: MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.58 (-2.10%)
MDWD NASDAQ Mediwound Ltd
Mediwound Ltd share price
MDWD price activity
Último preço
$ 12,580
Variação (24h)
-0,27 USD (-2,10%)
Volume
61.39K
Volume (média 4 sem.)
-
Abertura
$ 12,80
Variação do dia
$ 12,43 - $ 13,11
Fechamento anterior
$ 12,85
Último negócio
08 Oct, 6:57 pm GMT+0
Atrasado
08 Oct, 6:57 pm GMT+0
MDWD price performance
Atrasado
08 Oct, 6:57 pm GMT+0
quote.marketSignals